Novartis
NVS · NYSE
Bulios Fair Price
$135.68
3.6% downside
Trenutna cena
$140.74
Po podatkih Bulios Fair Price se delnica NVS trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Novartis AG is a Swiss global pharmaceutical company with a broad portfolio of medicines and healthcare products. The company is one of the leading players in the pharmaceutical industry and operates worldwide. Novartis focuses on the development, manufacturing, and distribution of innovative medicines in various therapeutic areas, including oncology, cardiology, ophthalmology, neurology, and others. The company also specializes in the production and sale of generic drugs. Novartis dedicates significant efforts to research and development of new treatment options to help improve the quality of life for patients around the world. The company actively collaborates with medical professionals and institutions to ensure the best care for patients. Novartis AG (NVS) shares are an attractive choice for investors who follow the pharmaceutical industry and seek investment opportunities in a reputable company with a rich medical portfolio and a long history of innovation.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vasant Narasimhan
Employees
75,267
Headquarters
Basel
Prihajajoči dogodki
Earnings
Upcoming earnings report